Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared on LinkedIn:
“One of the best things about conferences is the opportunity to reconnect with former colleagues and friends.
It was a real pleasure to catch up with Matija Snuderl.
We were both fellows at MGH in Dr. Rakesh Jain’s lab, where we worked together and published several papers on glioblastoma (GBM).
I still remember the passion we shared for advancing the field and, ultimately, moving the needle for patients with GBM.
Years later, that passion has only grown stronger. It was wonderful to reconnect, exchange ideas, and realize how much more there is for us to do.
Looking forward to finding new ways to collaborate!”
You can also read:
Walid Kamoun: Strategies to Improve Neuro-Oncology Clinical Trial Success at SNO 2026.
Servier Pharmaceuticals Connects Healthcare Professionals Around pLGG at SNO 2026.
Zouina Sarfraz: Presenting New Studies on Melanoma and Lung Cancer Brain Metastases at SNO 2026.
Presenting New Neuro-Oncology Data Across 9 Presentations at SNO 2026 – Servier Pharmaceuticals.